Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Oncology

Cancer Stem Cells in Basic Science and in Translational Oncology: Can We Translate Into Clinical Application?

Journal of Hematology and Oncology

English

162P: Molecular Markers in Advanced Non Small Cell Lung Cancer Patients Receiving Gemcitabine & Cisplatin

Journal of Thoracic Oncology

English

Impact of Pretreatment Interstitial Lung Disease on Radiation Pneumonitis and Survival After Stereotactic Body Radiation Therapy for Lung Cancer

Journal of Thoracic Oncology

English

1330: Brigatinib Efficacy and Safety in Patients (Pts) With Anaplastic Lymphoma Kinase (ALK)-positive (ALK+) Non-Small Cell Lung Cancer (NSCLC) in a Phase 1/2 Trial

Journal of Thoracic Oncology

English

Racial Differences in Lung Cancer Genetics

Journal of Thoracic Oncology

English

All-Comers Versus Enrichment Design Strategy in Phase II Trials

Journal of Thoracic Oncology

English

Erratum To: NLK Functions to Maintain Proliferation and Stemness of NSCLC and Is a Target of Metformin

Journal of Hematology and Oncology

English

98O: Characterization of Tumor Infiltrating Lymphocytes in Resectable Early Stage Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

English

Circulating Osteopontin: A Dual Marker of Bone Destruction and Angiogenesis in Patients With Multiple Myeloma

Journal of Hematology and Oncology

English

EGFR delE709_T710insD: A Rare but Potentially EGFR Inhibitor Responsive Mutation in Non–Small-Cell Lung Cancer

Journal of Thoracic Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Oncology

Cancer Stem Cells in Basic Science and in Translational Oncology: Can We Translate Into Clinical Application?

162P: Molecular Markers in Advanced Non Small Cell Lung Cancer Patients Receiving Gemcitabine & Cisplatin

Impact of Pretreatment Interstitial Lung Disease on Radiation Pneumonitis and Survival After Stereotactic Body Radiation Therapy for Lung Cancer

1330: Brigatinib Efficacy and Safety in Patients (Pts) With Anaplastic Lymphoma Kinase (ALK)-positive (ALK+) Non-Small Cell Lung Cancer (NSCLC) in a Phase 1/2 Trial

Racial Differences in Lung Cancer Genetics

All-Comers Versus Enrichment Design Strategy in Phase II Trials

Erratum To: NLK Functions to Maintain Proliferation and Stemness of NSCLC and Is a Target of Metformin

98O: Characterization of Tumor Infiltrating Lymphocytes in Resectable Early Stage Non-Small Cell Lung Cancer

Circulating Osteopontin: A Dual Marker of Bone Destruction and Angiogenesis in Patients With Multiple Myeloma

EGFR delE709_T710insD: A Rare but Potentially EGFR Inhibitor Responsive Mutation in Non–Small-Cell Lung Cancer